Trademark: 88202247
Word
ABECMA
Status
Registered
Status Code
700
Status Date
Tuesday, January 14, 2020
Serial Number
88202247
Registration Number
5958800
Registration Date
Tuesday, January 14, 2020
Mark Type
4000
Filing Date
Wednesday, November 21, 2018
Published for Opposition
Tuesday, October 29, 2019

Trademark Owner History
Celgene Corporation - Original Registrant

Classifications
5 Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Trademark Events
Dec 9, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 9, 2022
Teas Change Of Correspondence Received
Dec 9, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 9, 2022
Teas Change Of Owner Address Received
Jan 14, 2020
Registered-Principal Register
Oct 29, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 29, 2019
Published For Opposition
Oct 9, 2019
Notification Of Notice Of Publication E-Mailed
Sep 19, 2019
Approved For Pub - Principal Register
Sep 16, 2019
Examiner's Amendment Entered
Sep 16, 2019
Notification Of Examiners Amendment E-Mailed
Sep 16, 2019
Examiners Amendment E-Mailed
Sep 16, 2019
Examiners Amendment -Written
Sep 5, 2019
Teas/Email Correspondence Entered
Sep 5, 2019
Correspondence Received In Law Office
Sep 3, 2019
Assigned To Lie
Aug 22, 2019
Assigned To Lie
Aug 14, 2019
Teas Response To Suspension Inquiry Received
Feb 26, 2019
Notification Of Letter Of Suspension E-Mailed
Feb 26, 2019
Letter Of Suspension E-Mailed
Feb 26, 2019
Suspension Letter Written
Feb 25, 2019
Assigned To Examiner
Feb 22, 2019
Teas Voluntary Amendment Received
Dec 11, 2018
New Application Office Supplied Data Entered In Tram
Nov 24, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24